Pasar al contenido principal

Granja in vitro: desarrollo del primer biobanco de organoides de animales de granja como alternativa a los experimentos con animales en la investigación de enfermedades infecciosas (FARMBANK)

PLEC2022-009171

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Líneas Estratégicas
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES (IRTA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes

  • Molina Molina, Elisa
  • Bech-Serra, Joan Josep
  • Franco-Trepat, Eloi
  • Jarne, Ignasi
  • Perez-Zsolt, Daniel
  • Badia, Roger
  • Riveira-Muñoz, Eva
  • Garcia-Vidal, Edurne
  • Revilla, Lluís
  • Franco, Sandra
  • Tarrés Freixas, Ferran
  • Roca, Núria
  • Ceada, Gerardo
  • Kochanowski, Karl
  • Raïch-Regué, Dàlia
  • Erkizia, Itziar
  • Boreika, Rytis
  • Bordoy, Antoni E.
  • Soler, Laia
  • Guil, Sonia
  • Carrillo, Jorge
  • Blanco, Julià
  • Martínez, Miguel Ángel
  • Paredes, Roger
  • Losada, Alejandro
  • Aviles, Pablo
  • Cuevas, Carmen
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • Clotet, Bonaventura
  • Ballana, Ester
  • de la Torre, Carolina
  • Izquierdo-Useros, Nuria
Plitidepsin is an antitumoral compound safe for treating COVID-19 that targets the translation elongation factor eEF1A. Here we detect that plitidepsin decreases de novo cap-dependent translation of SARS-CoV-2 and non-viral RNAs but affects less than 13% of the host proteome, thus preserving cellular viability. In response to plitidepsin, cells upregulate EIF2AK3 and proteins that reduce translation, but also proteins that support proteostasis via ribosome synthesis and cap-independent translation by eIF4G2 and IGF2BP2. While plitidepsin inhibits cap- or internal ribosome entry sites (IRES)-mediated translation, its impact on N6-methyladenosine (m6A) translation is limited. In agreement, plitidepsin blocks members of Coronaviridae, Flaviviridae, Pneumoviridae and Herpesviridae families. Yet, it fails to inhibit retroviruses that exploit m6A synthesis routes and are blocked by drugs targeting IGF2BP2 m6A reader. By deciphering the molecular fingerprint of cells treated with therapies targeting translation we identify a rational approach to select broad-spectrum antivirals with potential to counteract future pandemic viruses., N.I-U. is supported by the Spanish Ministry of Science and Innovation (grants PID2020-117145RB-I00, PID2023-147498OB-I00 and 10.13039/501100011033, Spain), EU HORIZON-HLTH-2021CORONA-01 (grant 101046118, European Union) and by institutional funding of PharmaMar, Grifols, HIPRA, and Amassence. E.M-M. is supported by the Spanish Ministry of Science and Innovation (grant PRE2021-099271). E.F-T is supported by JDC2023-050389-I funded by MCIU/AEI/10.13039/501100011033 and FSE+. E.G-V. is a research fellow from PERIS (SLT017/20/000090). E.B. and R.B. are research fellows from ISCIII-FIS (CPII19/00012; CP19/00011). K.K. is supported by funding from the Spanish Ministry of Research and Innovation (RYC2021-033035-I/AEI/10.13039/501100011033). G.C. is supported with funding from PLEC2022-009171/AEI/10.13039/501100011033. IrsiCaixa is supported by 2021 SGR 0045. The proteomic analyses were conducted at the IJC Proteomics Unit, which is affiliated with the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the Spanish Platform of Molecular and Bioinformatics Resources (ProteoRed), Instituto de Salud Carlos III (PT17/0019), and CERCA GINYNS. This unit serves as a gateway to scientific and technical infrastructures. We acknowledge J. Díaz from the CMCiB for his constant help at the BSL3 facility. We thank the contribution of E. Martró and V. Saludes from the Microbiology department of HUGTIP for their constant help to identify and sequence SARS-CoV-2 variants. The authors also acknowledge the crowdfunding initiative #Yomecorono (https://www.yomecorono.com) and Foundation Dormeur for financial support for the acquisition of the QuantStudio-5 real-time PCR system and an Eclipse Ts2RFL inverted research microscope., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Airway organoids reveal patterns of influenza A tropism and adaptation in wildlife species

  • Tarrés Freixas, Ferran
  • Ceada, Gerardo
  • Català-Moll, Francesc
  • Casadellà, Maria
  • Tolosa-Alarcón, Sara
  • Franco-Trepat, Eloi
  • Boreika, Rytis
  • Almagro-Delgado, Vanessa
  • Carmona, Noelia
  • Estruch, Josep
  • Fernández-Bellon, Hugo
  • Fuentes-Moyano, Laura
  • Molina-López, Rafael
  • Navarro, Nuria
  • Parera, Mariona
  • Pérez Simó, Marta
  • Repullés, Joan
  • Roca, Núria
  • Torne, Odalys
  • Velarde, Roser
  • Valencia, Alfonso
  • Paredes, Roger
  • Izquierdo-Useros, Nuria
  • Romero-Durana, Miguel
  • Kochanowski, Karl
  • Vergara-Alert, Júlia
Identifying animal species that are susceptible to the plethora of existing and emerging viruses is critical for predicting and containing disease outbreaks. Current efforts to assess viral tropism largely rely on experimental infection models, but such experiments are logistically and ethically infeasible for many wildlife species. To tackle this challenge, we developed a panel of airway organoids from ten taxonomically diverse wildlife and livestock species and evaluated their susceptibility to influenza viruses of mammalian (pH1N1) and avian (H5N1) origin. Our analyses revealed large host-specific differences in infection rate and cytopathogenicity that aligned with known in vivo data and field observations. Furthermore, we demonstrated that this organoid panel can serve as a powerful tool to elucidate receptor-binding mechanisms, viral dynamics and early host adaptation in poorly characterized animal hosts. In summary, this work provides a robust and ethically viable approach for evaluating viral tropism and adaptation in wildlife species, and may aid current pandemic preparedness, zoonotic disease surveillance and wildlife conservation efforts., This project was supported by a “Proyectos en lineas estratégicas” grant from the Spanish Ministry of Research and Innovation (project ID: PLEC2022-009171 /AEI/10.13039/501100011033). KK acknowledges additional support by the Spanish Ministry of Research and Innovation (RYC2021-033035-I /AEI/10.13039/501100011033). N.I-U. is supported by the Spanish Ministry of Science and Innovation (grants PID2023-147498OB-I00 /AEI/10.13039/501100011033), EU HORIZON-HLTH-2021 CORONA-01 (grant 101046118), EU HORIZON-HLTH-2023-DISEASE-03, and by institutional funding from PharmaMar, HIPRA, Amassence and Smart Vitamins. NIU is part of PTI-CSIC Salud Global. The authors also thank the support of CERCA and Fundación Dormeur. E.F.-T. is supported by JDC2023050389-I. MRD was supported by a fellowship within the “Generación D” initiative, Red.es, Ministerio para la Transformación Digital y de la Función Pública, for talent attraction (C005/24-ED CV1), funded by the European Union NextGenerationEU funds through PRTR. The authors also acknowledge the crowdfunding initiative #Yomecorono, available online at https://www.yomecorono.com., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes

  • Molina Molina, Elisa
  • Bech-Serra, Joan Josep
  • Franco-Trepat, Eloi
  • Jarne, Ignasi
  • Perez-Zsolt, Daniel
  • Badia, Roger
  • Riveira-Muñoz, Eva
  • Garcia-Vidal, Edurne
  • Revilla, Lluís
  • Franco, Sandra
  • Tarrés Freixas, Ferran
  • Roca, Núria
  • Ceada, Gerardo
  • Kochanowski, Karl
  • Raïch-Regué, Dàlia
  • Erkizia, Itziar
  • Boreika, Rytis
  • Bordoy, Antoni E.
  • Soler, Laia
  • Guil, Sonia
  • Carrillo, Jorge
  • Blanco, Julià
  • Martínez, Miguel Ángel
  • Paredes, Roger
  • Losada, Alejandro
  • Aviles, Pablo
  • Cuevas, Carmen
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • Clotet, Bonaventura
  • Ballana, Ester
  • de la Torre, Carolina
  • Izquierdo-Useros, Nuria
Plitidepsin is an antitumoral compound safe for treating COVID-19 that targets the translation elongation factor eEF1A. Here we detect that plitidepsin decreases de novo cap-dependent translation of SARS-CoV-2 and non-viral RNAs but affects less than 13% of the host proteome, thus preserving cellular viability. In response to plitidepsin, cells upregulate EIF2AK3 and proteins that reduce translation, but also proteins that support proteostasis via ribosome synthesis and cap-independent translation by eIF4G2 and IGF2BP2. While plitidepsin inhibits cap- or internal ribosome entry sites (IRES)-mediated translation, its impact on N6-methyladenosine (m6A) translation is limited. In agreement, plitidepsin blocks members of Coronaviridae, Flaviviridae, Pneumoviridae and Herpesviridae families. Yet, it fails to inhibit retroviruses that exploit m6A synthesis routes and are blocked by drugs targeting IGF2BP2 m6A reader. By deciphering the molecular fingerprint of cells treated with therapies targeting translation we identify a rational approach to select broad-spectrum antivirals with potential to counteract future pandemic viruses., N.I-U. is supported by the Spanish Ministry of Science and Innovation (grants PID2020-117145RB-I00, PID2023-147498OB-I00 and 10.13039/501100011033, Spain), EU HORIZON-HLTH-2021CORONA-01 (grant 101046118, European Union) and by institutional funding of PharmaMar, Grifols, HIPRA, and Amassence. E.M-M. is supported by the Spanish Ministry of Science and Innovation (grant PRE2021-099271). E.F-T is supported by JDC2023-050389-I funded by MCIU/AEI/10.13039/501100011033 and FSE+. E.G-V. is a research fellow from PERIS (SLT017/20/000090). E.B. and R.B. are research fellows from ISCIII-FIS (CPII19/00012; CP19/00011). K.K. is supported by funding from the Spanish Ministry of Research and Innovation (RYC2021-033035-I/AEI/10.13039/501100011033). G.C. is supported with funding from PLEC2022-009171/AEI/10.13039/501100011033. IrsiCaixa is supported by 2021 SGR 0045. The proteomic analyses were conducted at the IJC Proteomics Unit, which is affiliated with the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the Spanish Platform of Molecular and Bioinformatics Resources (ProteoRed), Instituto de Salud Carlos III (PT17/0019), and CERCA GINYNS. This unit serves as a gateway to scientific and technical infrastructures. We acknowledge J. Díaz from the CMCiB for his constant help at the BSL3 facility. We thank the contribution of E. Martró and V. Saludes from the Microbiology department of HUGTIP for their constant help to identify and sequence SARS-CoV-2 variants. The authors also acknowledge the crowdfunding initiative #Yomecorono (https://www.yomecorono.com) and Foundation Dormeur for financial support for the acquisition of the QuantStudio-5 real-time PCR system and an Eclipse Ts2RFL inverted research microscope., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Airway organoids reveal patterns of influenza A tropism and adaptation in wildlife species

  • Tarrés Freixas, Ferran
  • Ceada, Gerardo
  • Català-Moll, Francesc
  • Casadellà, Maria
  • Tolosa-Alarcón, Sara
  • Franco-Trepat, Eloi
  • Boreika, Rytis
  • Almagro-Delgado, Vanessa
  • Carmona, Noelia
  • Estruch, Josep
  • Fernández-Bellon, Hugo
  • Fuentes-Moyano, Laura
  • Molina-López, Rafael
  • Navarro, Nuria
  • Parera, Mariona
  • Pérez Simó, Marta
  • Repullés, Joan
  • Roca, Núria
  • Torne, Odalys
  • Velarde, Roser
  • Valencia, Alfonso
  • Paredes, Roger
  • Izquierdo-Useros, Nuria
  • Romero-Durana, Miguel
  • Kochanowski, Karl
  • Vergara-Alert, Júlia
Identifying animal species that are susceptible to the plethora of existing and emerging viruses is critical for predicting and containing disease outbreaks. Current efforts to assess viral tropism largely rely on experimental infection models, but such experiments are logistically and ethically infeasible for many wildlife species. To tackle this challenge, we developed a panel of airway organoids from ten taxonomically diverse wildlife and livestock species and evaluated their susceptibility to influenza viruses of mammalian (pH1N1) and avian (H5N1) origin. Our analyses revealed large host-specific differences in infection rate and cytopathogenicity that aligned with known in vivo data and field observations. Furthermore, we demonstrated that this organoid panel can serve as a powerful tool to elucidate receptor-binding mechanisms, viral dynamics and early host adaptation in poorly characterized animal hosts. In summary, this work provides a robust and ethically viable approach for evaluating viral tropism and adaptation in wildlife species, and may aid current pandemic preparedness, zoonotic disease surveillance and wildlife conservation efforts., This project was supported by a “Proyectos en lineas estratégicas” grant from the Spanish Ministry of Research and Innovation (project ID: PLEC2022-009171 /AEI/10.13039/501100011033). KK acknowledges additional support by the Spanish Ministry of Research and Innovation (RYC2021-033035-I /AEI/10.13039/501100011033). N.I-U. is supported by the Spanish Ministry of Science and Innovation (grants PID2023-147498OB-I00 /AEI/10.13039/501100011033), EU HORIZON-HLTH-2021 CORONA-01 (grant 101046118), EU HORIZON-HLTH-2023-DISEASE-03, and by institutional funding from PharmaMar, HIPRA, Amassence and Smart Vitamins. NIU is part of PTI-CSIC Salud Global. The authors also thank the support of CERCA and Fundación Dormeur. E.F.-T. is supported by JDC2023050389-I. MRD was supported by a fellowship within the “Generación D” initiative, Red.es, Ministerio para la Transformación Digital y de la Función Pública, for talent attraction (C005/24-ED CV1), funded by the European Union NextGenerationEU funds through PRTR. The authors also acknowledge the crowdfunding initiative #Yomecorono, available online at https://www.yomecorono.com., info:eu-repo/semantics/publishedVersion